Clinical trial
Recombinant Human Thrombopoietin in Children Receiving Ifosfamide, Carboplatin…
NCT00187109 · St. Jude Children's Research Hospital, Other · Completed
Key facts
| NCT number | NCT00187109 |
|---|---|
| Title | Recombinant Human Thrombopoietin in Children Receiving Ifosfamide, Carboplatin, and Etoposide Chemotherapy |
| Official title | A Phase I/II Trial of Recombinant Human Thrombopoietin in Children With Malignant Solid Tumors and Lymphoma Receiving Ifosfamide, Carboplatin and Etoposide |
| Lead sponsor | St. Jude Children's Research Hospital, Other |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Germ Cell Tumors, Hepatic Cancer, Neuroblastoma, Osteosarcoma, Rhabdomyosarcoma |
| Intervention type | Drug |
| Interventions | Recombinant Human Thrombopoietin |
| Enrollment | 40 |
| Start date | Jun 1, 2000 |
| Primary completion | Feb 1, 2007 |
| Completion | Feb 1, 2007 |
| First posted | Sep 16, 2005 |
| Last update posted | Apr 10, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: